Status:
COMPLETED
To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects
Lead Sponsor:
Pfizer
Conditions:
Pain
Eligibility:
MALE
21-55 years
Brief Summary
The purpose of the study is to investigate the safety, toleration and pharmacokinetics of single oral doses of PF-04531083 in healthy male subjects.
Eligibility Criteria
Inclusion
- young
- healthy
- male
Exclusion
- elderly
- unhealthy
- female
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00992316
Start Date
August 1 2009
End Date
December 1 2009
Last Update
December 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Brussels, Belgium, 1070